Carlo Buonerba

Also affiliated with Associazione Italiana Di Oncologia Medica, CTO Andrea Alesini, University of Naples Federico II

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “The influence of immunocompromised status on recurrence and progression free survival among nonmuscle invasive bladder cancers (NMIBCs) undergoing transurethral resection of bladder tumor (TURBT) and adjuvant intravesical bacillus Calmette Guerin (BCG): Analysis of USA insurance claim data”.

The influence of immunocompromised status on recurrence and progression free survival among nonmuscle invasive bladder cancers (NMIBCs) undergoing transurethral resection of bladder tumor (TURBT) and adjuvant intravesical bacillus Calmette Guerin (BCG): Analysis of USA insurance claim data

Urologic Oncology Seminars and Original Investigations(2025)10.1016/j.urolonc.2025.07.005

N/A

0DataRank · unranked

1 citations

Valerio Santarelli, Jan Łaszkiewicz, Shufeng Li, Wojciech Krajewski, Łukasz Nowak +25 more